(Q53268701)

12 May 2018

title

Outcome of children with refractory anaemia with excess of blast (RAEB) and RAEB in transformation (RAEB-T) in the Japanese MDS99 study. (English)

1 reference

12 May 2018

1 reference

2

1 reference

12 May 2018

Atsushi Manabe

8

object named as

Atsushi Manabe

1 reference

12 May 2018

author name string

Akira Kikuchi

1

1 reference

12 May 2018

Yoshitoshi Ohtsuka

3

1 reference

12 May 2018

Kazuko Hamamoto

4

1 reference

12 May 2018

Seiji Kojima

5

1 reference

12 May 2018

Jun Okamura

6

1 reference

12 May 2018

Tatsutoshi Nakahata

7

1 reference

12 May 2018

Japanese Paediatric Myelodysplastic Syndrome (MDS) Study Group

9

1 reference

12 May 2018

language of work or name

English

0 references

publication date

26 June 2012

1 reference

12 May 2018

British Journal of Haematology

published in

1 reference

12 May 2018

volume

158

1 reference

12 May 2018

issue

5

1 reference

12 May 2018

page(s)

657-661

1 reference

12 May 2018

Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09210.X

The role of intensive AML-specific therapy in treatment of children with RAEB and RAEB-t.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09210.X

Treatment of children with refractory anemia: the Japanese Childhood MDS Study Group trial (MDS99).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09210.X

Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09210.X

Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09210.X

Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09210.X

Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09210.X

Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09210.X

10.1111/J.1365-2141.2012.09210.X

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018